Overview UK Study Assessing Flexible Dose Fesoterodine in Adults Status: Completed Trial end date: 2010-01-01 Target enrollment: Participant gender: Summary To explore the effects of fesoterodine when used in a flexible dose manner Phase: Phase 4 Details Lead Sponsor: PfizerTreatments: Fesoterodine